Why the study?
Does HP LC-MS/MS urine analysis identify non-adherence to antihypertensive treatment in patients with suboptimal blood pressure control?
Does HP LC-MS/MS urine analysis identify non-adherence to antihypertensive treatment in patients with suboptimal blood pressure control?
HP LC-MS/MS urine analysis may be a useful tool to exclude non-adherence in patients with suboptimal blood pressure control prior to further interventions like renal denervation.
LC-MS/MS urine analysis detects high non-adherence in uncontrolled hypertension; leaves open whether routine use improves outcomes before renal denervation.
Non-adherence to blood pressure lowering therapy is common, particularly in patients with suboptimal blood pressure control and those referred for renal denervation. HP LC-MS/MS urine analysis could be used to exclude non-adherence and better stratify further investigations and intervention.
No takes yet. Share an insight, caveat, or question.
Tomaszewski et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: